Stay updated on OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial
Sign up to get notified when there's something new on the OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial page.

Latest updates to the OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a new medical research citation (PRIMROSE 1 & 2 study) related to linzagolix for uterine fibroids; no deletions were observed.SummaryDifference2%

- Check27 days agoChange Detected- Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check34 days agoChange DetectedUpdate page revision from v3.0.2 to v3.1.0 to reflect a new release.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.SummaryDifference0.2%

- Check56 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%

- Check63 days agoChange DetectedThe web page has been updated to include new drug information for Linzagolix and additional locations in Europe, while some previous location names and related medical topics have been removed.SummaryDifference9%

Stay in the know with updates to OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial page.